Target intelligence / Profile preview

Schistosome voltage-gated calcium channel beta subunit (Cavβ subunit (or Cavβ, context-specific notation in literature))

Target
Cavβ subunit (or Cavβ, context-specific notation in literature)
Molecular classification
Ion channel auxiliary subunit, Voltage-gated calcium channel subunit
01

Overview

The **Schistosome voltage-gated calcium channel beta subunit** is an auxiliary component of the voltage-gated calcium (Cav) channel complex in schistosome parasites, notably Schistosoma mansoni. The beta subunit plays a crucial role in trafficking the channel’s alpha subunit to the plasma membrane, regulating channel gating, and modulating the biophysical properties of calcium influx, which is essential for neuromuscular function in the parasite[1][2][4]. This subunit shows unique sequence and structural features compared to mammalian beta subunits, making it a promising parasite-specific drug target. Recent research implicates the beta subunit in the action of praziquantel, the primary drug used for schistosomiasis treatment, though its precise molecular role remains under investigation. The parasite-specific nature and central role in neuromuscular physiology highlight its importance as an anthelmintic drug target and its potential relevance for understanding praziquantel resistance[1][4][5].

Other names
Voltage-gated calcium channel β subunit (schistosome)Cavβ subunit (schistosome)Platyhelminth Cavβvar (variant beta subunit)Schistosoma mansoni CavβVoltage-gated calcium channel auxiliary β subunit (schistosome)
02

Mechanism of action

Modulation of calcium homeostasis through interaction with the voltage-gated calcium channel complex (evidence supports the β subunit involvement in praziquantel action, but the molecular mechanism remains incompletely defined)[1][5][4].

03

Biological functions

Regulation of calcium channel traffickingModulation of calcium channel gating kineticsNeuromuscular signal transductionRegulation of calcium influx
04

Disease associations

Infection (Schistosomiasis, caused by Schistosoma species)Other (Central for neuromuscular physiology in the parasite, may affect drug resistance)
05

Safety considerations

Drug resistance to praziquantel is an emerging concernSelectivity: targeting schistosome-specific subunit variants is desirable to avoid host off-target effects[5]
06

Interacting drugs

Praziquantel (current first-line therapy for schistosomiasis)
07

Biomarkers

Potential for use in resistance marker development in schistosomes (but not yet clinically established)[5]

Beyond the preview

Go deeper on Schistosome voltage-gated calcium channel beta subunit (Cavβ subunit (or Cavβ, context-specific notation in literature)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Schistosome voltage-gated calcium channel beta subunit (Cavβ subunit (or Cavβ, context-specific notation in literature)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call